H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares trading hands.
H. Lundbeck A/S Stock Performance
The stock has a market cap of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68. The business has a 50 day moving average price of $22.00 and a 200 day moving average price of $22.00. The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Recommended Stories
- Five stocks we like better than H. Lundbeck A/S
- How to find penny stocks to invest and trade
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Stock Average Calculator
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- 5 Top Rated Dividend Stocks to Consider
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
